Click for best price
Urology Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Urology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urology Drugs. This report contains market size and forecasts of Urology Drugs in global, including the following market information:
Global Urology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Urology Drugs Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Urology Drugs companies in 2022 (%)
The global Urology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
? (alpha) Blockers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Urology Drugs include Astellas, Endo, GP Pharm and Tolmar, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urology Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Urology Drugs Market Segment Percentages, by Type, 2022 (%)
? (alpha) Blockers
5 ?-reductase Inhibitors
Global Urology Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Urology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Urology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Urology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urology Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Urology Drugs revenues share in global market, 2022 (%)
Key companies Urology Drugs sales in global market, 2018-2023 (Estimated), (MT)
Key companies Urology Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas
Endo
GP Pharm
Tolmar
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urology Drugs, market overview.
Chapter 2: Global Urology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Urology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Urology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Urology Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
76 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Urology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urology Drugs Overall Market Size
2.1 Global Urology Drugs Market Size: 2022 VS 2029
2.2 Global Urology Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Urology Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Urology Drugs Players in Global Market
3.2 Top Global Urology Drugs Companies Ranked by Revenue
3.3 Global Urology Drugs Revenue by Companies
3.4 Global Urology Drugs Sales by Companies
3.5 Global Urology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Urology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Urology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Urology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Urology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Urology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Urology Drugs Market Size Markets, 2022 & 2029
4.1.2 ? (alpha) Blockers
4.1.3 5 ?-reductase Inhibitors
4.2 By Type - Global Urology Drugs Revenue & Forecasts
4.2.1 By Type - Global Urology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Urology Drugs Revenue, 2024-2029
4.2.3 By Type - Global Urology Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Urology Drugs Sales & Forecasts
4.3.1 By Type - Global Urology Drugs Sales, 2018-2023
4.3.2 By Type - Global Urology Drugs Sales, 2024-2029
4.3.3 By Type - Global Urology Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Urology Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Urology Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Urology Drugs Revenue & Forecasts
5.2.1 By Application - Global Urology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Urology Drugs Revenue, 2024-2029
5.2.3 By Application - Global Urology Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Urology Drugs Sales & Forecasts
5.3.1 By Application - Global Urology Drugs Sales, 2018-2023
5.3.2 By Application - Global Urology Drugs Sales, 2024-2029
5.3.3 By Application - Global Urology Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Urology Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Urology Drugs Market Size, 2022 & 2029
6.2 By Region - Global Urology Drugs Revenue & Forecasts
6.2.1 By Region - Global Urology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Urology Drugs Revenue, 2024-2029
6.2.3 By Region - Global Urology Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Urology Drugs Sales & Forecasts
6.3.1 By Region - Global Urology Drugs Sales, 2018-2023
6.3.2 By Region - Global Urology Drugs Sales, 2024-2029
6.3.3 By Region - Global Urology Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Urology Drugs Revenue, 2018-2029
6.4.2 By Country - North America Urology Drugs Sales, 2018-2029
6.4.3 US Urology Drugs Market Size, 2018-2029
6.4.4 Canada Urology Drugs Market Size, 2018-2029
6.4.5 Mexico Urology Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Urology Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Urology Drugs Sales, 2018-2029
6.5.3 Germany Urology Drugs Market Size, 2018-2029
6.5.4 France Urology Drugs Market Size, 2018-2029
6.5.5 U.K. Urology Drugs Market Size, 2018-2029
6.5.6 Italy Urology Drugs Market Size, 2018-2029
6.5.7 Russia Urology Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Urology Drugs Market Size, 2018-2029
6.5.9 Benelux Urology Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Urology Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Urology Drugs Sales, 2018-2029
6.6.3 China Urology Drugs Market Size, 2018-2029
6.6.4 Japan Urology Drugs Market Size, 2018-2029
6.6.5 South Korea Urology Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Urology Drugs Market Size, 2018-2029
6.6.7 India Urology Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Urology Drugs Revenue, 2018-2029
6.7.2 By Country - South America Urology Drugs Sales, 2018-2029
6.7.3 Brazil Urology Drugs Market Size, 2018-2029
6.7.4 Argentina Urology Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Urology Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Urology Drugs Sales, 2018-2029
6.8.3 Turkey Urology Drugs Market Size, 2018-2029
6.8.4 Israel Urology Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Urology Drugs Market Size, 2018-2029
6.8.6 UAE Urology Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Astellas
7.1.1 Astellas Company Summary
7.1.2 Astellas Business Overview
7.1.3 Astellas Urology Drugs Major Product Offerings
7.1.4 Astellas Urology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Astellas Key News & Latest Developments
7.2 Endo
7.2.1 Endo Company Summary
7.2.2 Endo Business Overview
7.2.3 Endo Urology Drugs Major Product Offerings
7.2.4 Endo Urology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Endo Key News & Latest Developments
7.3 GP Pharm
7.3.1 GP Pharm Company Summary
7.3.2 GP Pharm Business Overview
7.3.3 GP Pharm Urology Drugs Major Product Offerings
7.3.4 GP Pharm Urology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 GP Pharm Key News & Latest Developments
7.4 Tolmar
7.4.1 Tolmar Company Summary
7.4.2 Tolmar Business Overview
7.4.3 Tolmar Urology Drugs Major Product Offerings
7.4.4 Tolmar Urology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Tolmar Key News & Latest Developments
8 Global Urology Drugs Production Capacity, Analysis
8.1 Global Urology Drugs Production Capacity, 2018-2029
8.2 Urology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Urology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Urology Drugs Supply Chain Analysis
10.1 Urology Drugs Industry Value Chain
10.2 Urology Drugs Upstream Market
10.3 Urology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Urology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Urology Drugs in Global Market
Table 2. Top Urology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Urology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Urology Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Urology Drugs Sales by Companies, (MT), 2018-2023
Table 6. Global Urology Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Urology Drugs Price (2018-2023) & (USD/Kg)
Table 8. Global Manufacturers Urology Drugs Product Type
Table 9. List of Global Tier 1 Urology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Urology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Urology Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Urology Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Urology Drugs Sales (MT), 2018-2023
Table 15. By Type - Global Urology Drugs Sales (MT), 2024-2029
Table 16. By Application ? Global Urology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Urology Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Urology Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Urology Drugs Sales (MT), 2018-2023
Table 20. By Application - Global Urology Drugs Sales (MT), 2024-2029
Table 21. By Region ? Global Urology Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Urology Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Urology Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Urology Drugs Sales (MT), 2018-2023
Table 25. By Region - Global Urology Drugs Sales (MT), 2024-2029
Table 26. By Country - North America Urology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Urology Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Urology Drugs Sales, (MT), 2018-2023
Table 29. By Country - North America Urology Drugs Sales, (MT), 2024-2029
Table 30. By Country - Europe Urology Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Urology Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Urology Drugs Sales, (MT), 2018-2023
Table 33. By Country - Europe Urology Drugs Sales, (MT), 2024-2029
Table 34. By Region - Asia Urology Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Urology Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Urology Drugs Sales, (MT), 2018-2023
Table 37. By Region - Asia Urology Drugs Sales, (MT), 2024-2029
Table 38. By Country - South America Urology Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Urology Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Urology Drugs Sales, (MT), 2018-2023
Table 41. By Country - South America Urology Drugs Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Urology Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Urology Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Urology Drugs Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Urology Drugs Sales, (MT), 2024-2029
Table 46. Astellas Company Summary
Table 47. Astellas Urology Drugs Product Offerings
Table 48. Astellas Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 49. Astellas Key News & Latest Developments
Table 50. Endo Company Summary
Table 51. Endo Urology Drugs Product Offerings
Table 52. Endo Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 53. Endo Key News & Latest Developments
Table 54. GP Pharm Company Summary
Table 55. GP Pharm Urology Drugs Product Offerings
Table 56. GP Pharm Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 57. GP Pharm Key News & Latest Developments
Table 58. Tolmar Company Summary
Table 59. Tolmar Urology Drugs Product Offerings
Table 60. Tolmar Urology Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2018-2023)
Table 61. Tolmar Key News & Latest Developments
Table 62. Urology Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 63. Global Urology Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Urology Drugs Production by Region, 2018-2023 (MT)
Table 65. Global Urology Drugs Production by Region, 2024-2029 (MT)
Table 66. Urology Drugs Market Opportunities & Trends in Global Market
Table 67. Urology Drugs Market Drivers in Global Market
Table 68. Urology Drugs Market Restraints in Global Market
Table 69. Urology Drugs Raw Materials
Table 70. Urology Drugs Raw Materials Suppliers in Global Market
Table 71. Typical Urology Drugs Downstream
Table 72. Urology Drugs Downstream Clients in Global Market
Table 73. Urology Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Urology Drugs Segment by Type in 2022
Figure 2. Urology Drugs Segment by Application in 2022
Figure 3. Global Urology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Urology Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Urology Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Urology Drugs Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Urology Drugs Revenue in 2022
Figure 9. By Type - Global Urology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Urology Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Urology Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Urology Drugs Price (USD/Kg), 2018-2029
Figure 13. By Application - Global Urology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Urology Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Urology Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Urology Drugs Price (USD/Kg), 2018-2029
Figure 17. By Region - Global Urology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Urology Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Urology Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Urology Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Urology Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Urology Drugs Sales Market Share, 2018-2029
Figure 23. US Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Urology Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Urology Drugs Sales Market Share, 2018-2029
Figure 28. Germany Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Urology Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Urology Drugs Sales Market Share, 2018-2029
Figure 37. China Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Urology Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Urology Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Urology Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Urology Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Urology Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Urology Drugs Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Urology Drugs by Region, 2022 VS 2029
Figure 54. Urology Drugs Industry Value Chain
Figure 55. Marketing Channels
